Marex Group President Sells $577,000 in Stock -- Here's What Investors Should Know

Key Points
Simon Van Den Born sold 13,264 shares for a total transaction value of approximately $577,000 on April 1, 2026.
The sale represented 0.86% of Van Den Born's direct holdings at the time, with post-transaction direct ownership totaling 1,522,229 shares.
Van Den Born retains direct holdings of 1,522,229 shares following the transaction.
- 10 stocks we like better than Marex Group Plc ›
Marex Group (NASDAQ:MRX) President Simon Van Den Born disclosed the sale of 13,264 shares in open-market transactions on April 1, 2026, according to an SEC Form 4 filing.
Transaction summary
| Metric | Value |
|---|---|
| Shares sold (direct) | 13,264 |
| Transaction value | ~$577,000 |
| Post-transaction shares (direct) | 1,522,229 |
| Post-transaction value (direct ownership) | ~$70.1 million |
Transaction value based on SEC Form 4 weighted average sale price ($43.51); post-transaction value based on April 6, 2026, market close ($46.02).
Key questions
- How does the transaction size compare to Van Den Born's prior trading activity?
A Form 144 filing submitted on the same date reveals a clear prior pattern: Van Den Born sold 14,000 shares per month in each of the three preceding months. The April 1 Form 4 sale of 13,264 shares is modestly smaller than that monthly pace but fits the same regular, pre-scheduled cadence, reinforcing that this appears to be part of a systematic, recurring trading program rather than a one-off or reactive event. - What proportion of Van Den Born's direct Marex Group holdings was affected?
The sale constituted 0.86% of direct holdings as of the transaction date, leaving the vast majority of the position intact. - Does Van Den Born maintain a substantial equity interest following this sale?
Yes, after the transaction, he continues to hold 1,522,229 direct shares, preserving a large equity position in Marex Group.
Company overview
| Metric | Value |
|---|---|
| Market cap | $3.3 billion |
| Revenue (TTM) | $3.6 billion |
| Net income (TTM) | $293.9 million |
| Dividend yield | 1.4% |
| 1-year price change* | 34% |
* 1-year performance calculated using April 6, 2026, as the reference date.
Company snapshot
Marex Group is a global financial services provider headquartered in London. The company provides liquidity, market access, and infrastructure services across commodities, energy, and financial markets, including execution and clearing in metals, agricultural products, energy, and financial futures and options.
- Operates a diversified business model spanning clearing, agency and execution, market making, and hedging and investment solutions, generating revenue through transaction fees, spreads, and customized risk management solutions.
- Serves trading houses, producers, consumers, banks, distributors, private banks, asset managers, pension funds, and corporates globally.
What this transaction means for investors
An executive selling stock often raises questions -- but context always matters, and this particular transaction is about as low-drama as insider sales get.
For starters, the sale was made under a pre-established Rule 10b5-1 trading plan that Van Den Born put in place back in December 2025. That's a key detail: these plans are set up in advance, during periods when executives have no material non-public information, and they execute automatically on a schedule. In other words, the decision to sell was made months ago -- it's not a reaction to anything happening at the company right now.
What's more, this isn't a new pattern. A Form 144 filing -- also submitted on April 1, 2026 -- shows that Van Den Born sold 14,000 shares on the first trading day of each of the prior three months. The April sale of 13,264 shares is actually a touch smaller than his recent monthly average. But when a sale fits so neatly into an established rhythm, it's hard to read much into it beyond routine portfolio management.
Then there's the sheer scale of what he kept. Van Den Born sold less than 1% of his direct holdings and still holds over 1.5 million shares. That's not the behavior of someone reducing their conviction in the business.
The backdrop for Marex itself is also worth noting. The company just issued strong updated guidance for Q1 2026, with projected revenues of $667 million to $697 million -- up roughly 43% to 49% from Q1 2025 -- and adjusted profit before tax climbing approximately 45% to 55% year over year, which would be a new quarterly record. The stock has risen meaningfully over the past 12 months, which makes periodic profit-taking all the more understandable.
For long-term investors, this filing is unlikely to shift the fundamental thesis on MRX one way or the other. The president still has plenty of skin in the game -- and the consistent, methodical nature of his selling makes this filing a non-event.
Should you buy stock in Marex Group Plc right now?
Before you buy stock in Marex Group Plc, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Marex Group Plc wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $533,522!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,089,028!*
Now, it’s worth noting Stock Advisor’s total average return is 930% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of April 7, 2026.
Andy Gould has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.